Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silodosin for symptomatic lower ureteral stones
ACTRN12611000555954Phase 4Completed
- Sponsor
- Chung Jing Wang
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of silodosin in ureterolithiasis, sponsored by Chung Jing Wang. Primary endpoints: Expulsion time and Expulsion rate. Started May 2010; status: completed.
02
Drugs
silodosin
03
Conditions
ureterolithiasis
Beyond the preview
Go deeper on ACTRN12611000555954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000555954.